Research

Spirulina extract’s effects on seniors’ health

October 10, 2013 — by Jack Mazurak
AlgaeIndustryMagazine.com

Dr. Gailen Marshall displays immulina in its capsule form.

Dr. Gailen Marshall displays immulina in its capsule form.

Can spirulina, the blue-green algae rich in linoleic acids, B vitamins and a variety of minerals – and used for centuries across ancient cultures to promote better health – improve immune systems in today’s seniors?

A clinical trial still enrolling participants is under way, at the University of Mississippi Medical Center (UMMC) in the Division of Allergy and Immunology, to test the theory that it may.

The pilot study at UMMC aims to identify whether and how much of the spirulina extract immulina it takes to improve the immune response of adults 60 and older. Seniors stand a greater risk for complications from colds, flu and other common infections.

“As people age, their susceptibility to mortality from influenza increases,” said Dr. Gailen Marshall, professor and R. Faser Triplet Sr. M.D. Chair in Allergy and Immunology. “Even the flu vaccine becomes less effective for them.”

Immulina magnified

Immulina magnified

Similarly, people’s immune systems weaken with age. That’s why older people die from infections, including flu, pneumonia, West Nile virus and sepsis, more often than younger people.

“If we can improve people’s immune system response with immulina, they may respond more robustly to the vaccine, which would better prepare their bodies to fight off the actual, live flu virus,” Marshall said.

He plans to enroll 50 people into the study. He began taking volunteers in August and will accept more on a rolling basis.

Participants will receive an envelope of pills – either immulina or a placebo – to take four times daily. They will visit a UMMC clinic weekly for four weeks to fill out questionnaires and give saliva samples and two tablespoons of blood.

After researchers collect the remaining pills, participants will make two return visits two weeks apart. By analyzing blood and saliva samples taken during and after the immulina treatment, Marshall and his team will be able to tell to what level and how long the immune-boosting effects lasted.

For the pilot study, Marshall is working with the National Center for Natural Products Research at the University of Mississippi, which is supplying and preparing the immulina. “I’ve collaborated for a couple years with Dr. Larry Walker and Dr. David Pascoe,” Marshall said. “They’d been working with immulina for a while and have considered it for use in cancer patients.”

If the results show promise, Marshall will apply to the National Institutes of Health to fund an investigation of immulina’s abilities to boost the effectiveness of flu vaccines in seniors. “That study would also consider whether immulina’s effects are different based on gender and race,” he said.

The pilot represents a piece in a larger puzzle, too. Marshall aims to establish a center for integrative medicine at UMMC that will investigate, teach and practice proven treatments and methods from the world’s major medical systems.

More Like This…

HOME A.I.M. Archives

Copyright ©2010-2015 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
U.S. farmers and biofuels makers are watching for the Environmental Protection Agency’s (EPA’s) final decision on the 2014 Renewable Fuel Standard rules, which will set t...
Caroline Scott-Thomas reports on Food Navigator about an online algae discussion on the social media site Reddit where Mars' chief agricultural officer Howard-Yana Shapir...
Kailua Kona, Hawaii-based Cyanotech has announced financial results for the third quarter and first nine months of fiscal year 2015, ended December 31, 2014. For the thir...
Solazyme has announced that total revenue for the fourth quarter of 2014 was $14.5 million, compared with $11.3 million in the fourth quarter of 2013, an increase of 29%....
Tom Redmond and Yuko Takeo report for Bloomberg.com that, after 10 years of developing algae as a nutritional supplement generating $37.8 million in annual revenue, Japan...
Dr. Gloria Naa Dzama Addico and Kweku Amoako Atta deGraft-Johnson write in Graphic Online about the plight of the fisher folks in Ghana — in the throes of depleting fish ...
With large-scale production at low cost a future possibility, many corporations in Japan are beginning to jump on the algae fuel bandwagon. Heavy industry giant IHI Corp....
Researchers at Michigan State University have built a molecular super protein tool that streamlines the molecular machinery of cyanobacteria making, they say, biofuels an...
Students of algal research, including it's various applications and business models, have increasing opportunities to get quickly up to speed in many aspects of the rapid...
The World Health Organization (WHO) estimates over 200 million people worldwide are exposed to arsenic concentrations in drinking water that exceed the guideline limit of...
A Memorandum of Agreement has been signed by Aerospace Malaysia Innovation Centre (AMIC), Airbus Group, University of Malaya, University Malaysia Terengganu, The Universi...
The GNT Group, a market leader in using algae as natural ingredients for color, has begun construction of an additional spirulina plant at its headquarters in Mierlo, the...